title: Eye muscle antibodies in endocrine exophthalmos. Clinical and serological observations.
abstract: Serum samples were obtained from 65 patients with endocrine exophthalmos class I-V. In 33/65 patients who were treated either with prednisone or with ciclosporin, blood was sampled before, during and after therapy. Antibodies against eye muscle were determined during the course of immunosuppressive therapy in order to have an objective parameter of the therapeutic effect. To ascertain the specificity of the reaction both eye and abdominal muscles were used as antigens in an ELISA system. Both IgG and IgM antibodies were detected. In 45/65 patients (71%) eye muscle antibodies were positive before starting therapy. Antibodies were mostly detected in patients with active disease. Patients with exophthalmos of recent onset always had IgM antibodies whereas patients with chronic exophthalmos were mostly IgG positive. Patients with relapse showed mostly IgG but also IgG and IgM positivity in 2 cases. In 58% of cases only IgG antibodies were found whereas in 34% both IgG and IgM were detected and in 8% only IgM antibodies. There was no association between antibodies directed against eye muscle and thyroid microsomal and thyroglobulin antibodies or with the state of thyroid function. Furthermore there was no correlation between exophthalmos classes and eye muscle antibody binding activity. The antibody level declined during therapy with prednisone or with ciclosporin but rose again 8-12 weeks after stopping the drug in patients with progressive disease.
authors.affiliation: Abteilung für Innere Medizin, Endokrinologie und Stoffwechsel, Universität Mainz, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Kahaly
authors.forename: R
authors.initials: R
authors.lastname: Moncayo
authors.forename: U
authors.initials: U
authors.lastname: Bemetz
authors.forename: U
authors.initials: U
authors.lastname: Krause
authors.forename: J
authors.initials: J
authors.lastname: Beyer
authors.forename: E F
authors.initials: EF
authors.lastname: Pfeiffer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000941:Antigens / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D002417:Cattle; D003524:Cyclosporins / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005094:Exophthalmos / Q000188:drug therapy / Q000276:immunology*; D005123:Eye / Q000276:immunology*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D011863:Radioimmunoassay; D013963:Thyroid Hormones / Q000097:blood / Q000276:immunology
chemical_list: D000941:Antigens; D001323:Autoantibodies; D003524:Cyclosporins; D007136:Immunoglobulins; D013963:Thyroid Hormones; D011241:Prednisone